PMID- 12804790 OWN - NLM STAT- MEDLINE DCOM- 20030814 LR - 20190916 IS - 0168-0102 (Print) IS - 0168-0102 (Linking) VI - 46 IP - 3 DP - 2003 Jul TI - Neurodegeneration of substantia nigra accompanied with macrophage/microglia infiltration after intrastriatal hemorrhage. PG - 289-98 AB - Intrastriatal hemorrhage in rats causes neurodegenaration of the substantia nigra (SN) followed by the appearance of ED1(+) cells (macrophage/microglia). ED1(+) cells were observed for at least 8 weeks after hemorrhage. Phosphorylation of p38 mitogen-activated protein kinase (MAPK) was shown in ED1(+) cells with the expression of both brain-derived neurotrophic factor (BDNF) mRNA and BDNF, suggesting that activated-p38 MAPK(+)/ED1(+) cells would produce BDNF and may exhibit trophic effect on the degenerating neurons in the SN. However, in ELISA, BDNF protein decreased significantly in ipsilateral SN at 7 days after hemorrhage, which may be due to a dramatic decrease of BDNF immunoreactive neurons in pars compacta. Data suggest that activation of p38 MAPK in ED1(+) cells infiltrating in ipsilateral SN after hemorrhage may produce BDNF, but that the amount of BDNF produced from ED1(+) cells is insufficient for the rescue of degenerating neurons. FAU - Imamura, Nobuki AU - Imamura N AD - Department of Neurosurgery and Restorative Neuroscience, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizoho-cho, Mizuho-ku, 467-8601, Nagoya, Japan. FAU - Hida, Hideki AU - Hida H FAU - Aihara, Noritaka AU - Aihara N FAU - Ishida, Kazuto AU - Ishida K FAU - Kanda, Yoshie AU - Kanda Y FAU - Nishino, Hitoo AU - Nishino H FAU - Yamada, Kazuo AU - Yamada K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Neurosci Res JT - Neuroscience research JID - 8500749 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Central Nervous System Stimulants) RN - 0 (Dopamine Agonists) RN - 0 (Ectodysplasins) RN - 0 (Membrane Proteins) RN - 0 (RNA, Messenger) RN - 44RAL3456C (Methamphetamine) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.4.24.- (Collagenases) RN - N21FAR7B4S (Apomorphine) SB - IM MH - Animals MH - Apomorphine/pharmacology MH - Behavior, Animal MH - Brain-Derived Neurotrophic Factor/biosynthesis/genetics MH - Central Nervous System Stimulants/pharmacology MH - Cerebral Hemorrhage/chemically induced/*complications/metabolism/pathology MH - Collagenases/toxicity MH - Disease Models, Animal MH - Dopamine Agonists/pharmacology MH - Ectodysplasins MH - Enzyme-Linked Immunosorbent Assay MH - Functional Laterality MH - Immunohistochemistry MH - In Situ Hybridization MH - Macrophages/*metabolism/pathology MH - Male MH - Membrane Proteins/metabolism MH - Methamphetamine/pharmacology MH - Microglia/*metabolism/pathology MH - Mitogen-Activated Protein Kinases/biosynthesis MH - Nerve Degeneration/*etiology/metabolism/pathology MH - RNA, Messenger/biosynthesis MH - Rats MH - Rats, Wistar MH - Rotation MH - Substantia Nigra/metabolism/*pathology MH - Time Factors MH - Tyrosine 3-Monooxygenase/metabolism MH - p38 Mitogen-Activated Protein Kinases EDAT- 2003/06/14 05:00 MHDA- 2003/08/15 05:00 CRDT- 2003/06/14 05:00 PHST- 2003/06/14 05:00 [pubmed] PHST- 2003/08/15 05:00 [medline] PHST- 2003/06/14 05:00 [entrez] AID - S0168010203000658 [pii] AID - 10.1016/s0168-0102(03)00065-8 [doi] PST - ppublish SO - Neurosci Res. 2003 Jul;46(3):289-98. doi: 10.1016/s0168-0102(03)00065-8.